Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Explore actionable methods to keep spending in check and align it with your budget. This intro provides simple, repeatable practices for effective management.
17,183 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
As investors look toward talen (tln) 2025 earnings, the Q4 transcript becomes the compass for revenue, margins, and g...
In 2026, the global air fleet is being renewed around a handful of high-performance fighters. Investors are watching ...
Could XRP slip below $2 by 2027? This guide breaks down the three big hurdles, explains why a lower price is plausibl...
Bitcoin has quieted its swings, but risk-aware investors are still buying protection. This guide explains why hedges ...
Exxon Mobil topped expectations in Q1 as LNG and Guyana projects accelerate. Investors are eyeing exxon mobil’s next ...
Curious about reliable income from your stock holdings without chasing risky growth? This guide explains what Fidelit...
Flyhomes has weathered a boom-bust housing cycle by recalibrating its business and embracing profitability over rapid...
A hedge fund trend today centers on a lean, two-name portfolio. INDUS Capital Partners boosted its bet on H World Gro...
Oregon's push to shift recycling costs to manufacturers promised cleaner streets and better recycling, but the rollou...
NVIDIA moves to secure critical design software by taking a $2 billion stake in Synopsys, signaling a deeper alignmen...
A high-conviction AI stock has turned heads as it climbs on stronger demand for AI infrastructure and software. This ...